optident labline limited
optident labline limited Company Information
Company Number
03629950
Website
www.optidentclearguide.co.ukRegistered Address
ground and first floors, the eng, pegholme mill, wharfebank mills,, otley, LS21 3JP
Industry
Wholesale of pharmaceutical goods
Telephone
01943886836
Next Accounts Due
2 days late
Group Structure
View All
Shareholders
henry schein uk holdings limited 100%
optident labline limited Estimated Valuation
Pomanda estimates the enterprise value of OPTIDENT LABLINE LIMITED at £344.8k based on a Turnover of £481.5k and 0.72x industry multiple (adjusted for size and gross margin).
optident labline limited Estimated Valuation
Pomanda estimates the enterprise value of OPTIDENT LABLINE LIMITED at £615k based on an EBITDA of £124.1k and a 4.96x industry multiple (adjusted for size and gross margin).
optident labline limited Estimated Valuation
Pomanda estimates the enterprise value of OPTIDENT LABLINE LIMITED at £888.7k based on Net Assets of £436.9k and 2.03x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Optident Labline Limited Overview
Optident Labline Limited is a live company located in otley, LS21 3JP with a Companies House number of 03629950. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in September 1998, it's largest shareholder is henry schein uk holdings limited with a 100% stake. Optident Labline Limited is a mature, micro sized company, Pomanda has estimated its turnover at £481.5k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Optident Labline Limited Health Check
Pomanda's financial health check has awarded Optident Labline Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs
6 Strong
0 Regular
4 Weak
Size
annual sales of £481.5k, make it smaller than the average company (£26.1m)
£481.5k - Optident Labline Limited
£26.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 7%, show it is growing at a faster rate (4.3%)
7% - Optident Labline Limited
4.3% - Industry AVG
Production
with a gross margin of 35.5%, this company has a lower cost of product (26.2%)
35.5% - Optident Labline Limited
26.2% - Industry AVG
Profitability
an operating margin of 25.8% make it more profitable than the average company (4%)
25.8% - Optident Labline Limited
4% - Industry AVG
Employees
with 5 employees, this is below the industry average (40)
5 - Optident Labline Limited
40 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Optident Labline Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £96.3k, this is less efficient (£636.6k)
£96.3k - Optident Labline Limited
£636.6k - Industry AVG
Debtor Days
it gets paid by customers after 32 days, this is earlier than average (59 days)
32 days - Optident Labline Limited
59 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (30 days)
0 days - Optident Labline Limited
30 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Optident Labline Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 227 weeks, this is more cash available to meet short term requirements (11 weeks)
227 weeks - Optident Labline Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 19.4%, this is a lower level of debt than the average (56.3%)
19.4% - Optident Labline Limited
56.3% - Industry AVG
OPTIDENT LABLINE LIMITED financials
Optident Labline Limited's latest turnover from December 2022 is £481.5 thousand and the company has net assets of £436.9 thousand. According to their latest financial statements, Optident Labline Limited has 5 employees and maintains cash reserves of £460.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 481,474 | 498,277 | 212,582 | 390,816 | 379,757 | 438,285 | 618,094 | 657,902 | 692,180 | 589,192 | 734,779 | 696,014 | ||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cost Of Sales | 310,598 | 303,639 | 151,784 | 258,400 | 277,089 | 307,817 | 427,898 | 407,698 | 413,555 | 346,754 | 392,483 | 454,638 | ||
| Gross Profit | 170,876 | 194,638 | 60,798 | 132,416 | 102,668 | 130,468 | 190,196 | 250,204 | 278,625 | 242,438 | 342,296 | 241,376 | ||
| Admin Expenses | 46,773 | 37,639 | 49,656 | 68,631 | 53,702 | 51,389 | 61,745 | 197,062 | 145,089 | 130,459 | ||||
| Operating Profit | 124,103 | 156,999 | 11,142 | 63,785 | 48,966 | 79,079 | 128,451 | 45,376 | 197,207 | 110,917 | ||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 632 | 3,790 | 3,790 | ||
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Pre-Tax Profit | 124,103 | 156,999 | 11,142 | 63,785 | 48,966 | 79,079 | 128,451 | 43,994 | -29,962 | 44,744 | 193,417 | 107,127 | ||
| Tax | -53,409 | 0 | -2,117 | -12,119 | -9,304 | -15,220 | -25,690 | -8,907 | 0 | 0 | -46,358 | -8,353 | ||
| Profit After Tax | 70,694 | 156,999 | 9,025 | 51,666 | 39,662 | 63,859 | 102,761 | 35,087 | -29,962 | 44,744 | 147,059 | 98,774 | ||
| Dividends Paid | 0 | 0 | 51,666 | 0 | 0 | 102,761 | 35,087 | 26,046 | 0 | 0 | 0 | 0 | ||
| Retained Profit | 70,694 | 156,999 | -42,641 | 51,666 | 39,662 | -38,902 | 67,674 | 9,041 | -29,962 | 44,744 | 147,059 | 98,774 | ||
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 165,138 | 173,194 | 56,949 | 48,917 | |||||
| Number Of Employees | 5 | 5 | 6 | 4 | 3 | 3 | ||||||||
| EBITDA* | 124,103 | 156,999 | 13,042 | 71,385 | 124,966 | 86,679 | 136,051 | 51,076 | 209,781 | 125,752 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21,708 | 28,943 | 38,590 |
| Intangible Assets | 0 | 0 | 0 | 1,900 | 9,500 | 17,100 | 24,700 | 32,300 | 39,900 | 47,500 | 53,200 | 60,800 | 68,400 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 1,900 | 9,500 | 17,100 | 24,700 | 32,300 | 39,900 | 47,500 | 53,200 | 82,508 | 97,343 | 38,590 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7,218 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 42,871 | 59,097 | 32,579 | 38,955 | 40,945 | 39,160 | 78,333 | 123,224 | 112,414 | 88,482 | 110,970 | 82,555 | 113,638 | 186,900 |
| Group Debtors | 38,412 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 1,500 | 14,212 | 3,337 | 6,906 | 5,212 | 7,275 | 0 | 0 | 1,746 | 161 | 10,397 | 0 | 0 |
| Cash | 460,819 | 450,520 | 282,858 | 329,148 | 462,632 | 644,441 | 913,527 | 306,164 | 70,008 | 102,417 | 77,003 | 22,875 | 94,775 | 75,327 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 542,102 | 511,117 | 329,649 | 371,440 | 510,483 | 688,813 | 999,135 | 429,388 | 189,640 | 192,645 | 188,134 | 115,827 | 208,413 | 262,227 |
| total assets | 542,102 | 511,117 | 329,649 | 373,340 | 519,983 | 705,913 | 1,023,835 | 461,688 | 229,540 | 240,145 | 241,334 | 198,335 | 305,756 | 300,817 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 239 | 23,278 | 1,442 | 16,402 | 17,107 | 17,515 | 18,480 | 0 | 10,899 | 21,818 | 15,205 | 34,234 | 389,999 | 420,570 |
| Group/Directors Accounts | 0 | 88,136 | 90,575 | 100,318 | 247,969 | 470,924 | 722,576 | 251,222 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,000 | 12,000 | 0 | 0 |
| other current liabilities | 104,960 | 33,494 | 28,422 | 4,769 | 15,060 | 17,289 | 43,692 | 39,053 | 56,269 | 25,993 | 76,539 | 149,570 | 0 | 0 |
| total current liabilities | 105,199 | 144,908 | 120,439 | 121,489 | 280,136 | 505,728 | 784,748 | 290,275 | 67,168 | 47,811 | 93,744 | 195,804 | 389,999 | 420,570 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,000 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14,000 | 26,000 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,000 | 14,000 | 26,000 |
| total liabilities | 105,199 | 144,908 | 120,439 | 121,489 | 280,136 | 505,728 | 784,748 | 290,275 | 67,168 | 47,811 | 93,744 | 197,804 | 403,999 | 446,570 |
| net assets | 436,903 | 366,209 | 209,210 | 251,851 | 239,847 | 200,185 | 239,087 | 171,413 | 162,372 | 192,334 | 147,590 | 531 | -98,243 | -145,753 |
| total shareholders funds | 436,903 | 366,209 | 209,210 | 251,851 | 239,847 | 200,185 | 239,087 | 171,413 | 162,372 | 192,334 | 147,590 | 531 | -98,243 | -145,753 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 124,103 | 156,999 | 11,142 | 63,785 | 48,966 | 79,079 | 128,451 | 45,376 | 197,207 | 110,917 | ||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,974 | 7,235 | 9,647 | 12,863 | |
| Amortisation | 0 | 0 | 1,900 | 7,600 | 76,000 | 7,600 | 7,600 | 7,600 | 7,600 | 5,700 | 7,600 | 7,600 | 7,600 | 0 |
| Tax | -53,409 | 0 | -2,117 | -12,119 | -9,304 | -15,220 | -25,690 | -8,907 | 0 | 0 | -46,358 | -8,353 | ||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7,218 | 7,218 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 20,686 | 13,806 | 4,499 | -5,559 | 3,479 | -41,236 | -37,616 | 10,810 | 22,186 | -2,724 | 18,179 | -20,686 | -73,262 | 186,900 |
| Creditors | -23,039 | 21,836 | -14,960 | -705 | -408 | -965 | 18,480 | -10,899 | -10,919 | -12,416 | -19,029 | -355,765 | -30,571 | 420,570 |
| Accruals and Deferred Income | 71,466 | 5,072 | 23,653 | -10,291 | -2,229 | -26,403 | 4,639 | -17,216 | 30,276 | -123,577 | -73,031 | 149,570 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 98,435 | 170,101 | 15,119 | 53,829 | 109,546 | 85,327 | 171,096 | 53,184 | -68,110 | |||||
| Investing Activities | ||||||||||||||
| capital expenditure | 0 | 0 | ||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | 0 | 0 | ||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -88,136 | -2,439 | -9,743 | -147,651 | -222,955 | -251,652 | 471,354 | 251,222 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14,000 | -12,000 | 14,000 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14,000 | -12,000 | 26,000 |
| share issue | ||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -632 | -3,790 | -3,790 | ||
| cash flow from financing | -88,136 | -2,439 | -9,743 | -187,313 | -222,955 | -251,652 | 471,354 | 251,222 | 0 | 132,427 | -15,790 | -3,790 | ||
| cash and cash equivalents | ||||||||||||||
| cash | 10,299 | 167,662 | -46,290 | -133,484 | -181,809 | -269,086 | 607,363 | 236,156 | -32,409 | 79,542 | 54,128 | -71,900 | 19,448 | 75,327 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 10,299 | 167,662 | -46,290 | -133,484 | -181,809 | -269,086 | 607,363 | 236,156 | -32,409 | 79,542 | 54,128 | -71,900 | 19,448 | 75,327 |
optident labline limited Credit Report and Business Information
Optident Labline Limited Competitor Analysis
Perform a competitor analysis for optident labline limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other micro companies, companies in LS21 area or any other competitors across 12 key performance metrics.
optident labline limited Ownership
OPTIDENT LABLINE LIMITED group structure
Optident Labline Limited has no subsidiary companies.
Ultimate parent company
HENRY SCHEIN INC
#0019121
2 parents
OPTIDENT LABLINE LIMITED
03629950
optident labline limited directors
Optident Labline Limited currently has 6 directors. The longest serving directors include Mr Adrian Martin (Feb 2013) and Mr Patrick Allen (Dec 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Adrian Martin | United Kingdom | 55 years | Feb 2013 | - | Director |
| Mr Patrick Allen | 58 years | Dec 2018 | - | Director | |
| Mr Michael Ettinger | United States | 63 years | Dec 2021 | - | Director |
| Mr Andrea Albertini | 54 years | Dec 2021 | - | Director | |
| Mr Andrea Albertini | 54 years | Dec 2021 | - | Director | |
| Mr Walter Siegel | United States | 65 years | Dec 2021 | - | Director |
P&L
December 2022turnover
481.5k
-3%
operating profit
124.1k
-21%
gross margin
35.5%
-9.14%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
436.9k
+0.19%
total assets
542.1k
+0.06%
cash
460.8k
+0.02%
net assets
Total assets minus all liabilities
optident labline limited company details
company number
03629950
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
September 1998
age
26
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
last accounts submitted
December 2022
address
ground and first floors, the eng, pegholme mill, wharfebank mills,, otley, LS21 3JP
accountant
BDO LLP
auditor
-
optident labline limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to optident labline limited. Currently there are 0 open charges and 2 have been satisfied in the past.
optident labline limited Companies House Filings - See Documents
| date | description | view/download |
|---|
